drugset / Trial / NCT04360915

Assessing the Pharmacokinetics Effects of Food on ASK120067 in Single Oral Administration in Chinese Healthy Subjects

NCT04360915

Phase 1 Completed 24 enrolled Jiangsu Aosaikang Pharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate the pharmacokinetic characteristics of ASK120067 and CCB4580030 after the single oral administration of ASK120067 in fast and after a high-fat meal in healthy Chinese subjects, and to evaluate the effect of food on the bioavailability of ASK120067.To evaluate the safety of ASK120067 tablets administered orally in fast and fed.

Timeline

Start
2019-12-09
Primary completion
2019-12-30
Completion
2019-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject ASK120067 Unknown 160 mg Oral

Indications

No indication recorded.